Drug maker pays Nebraska $2.6 million
Posted: Wednesday, December 31, 2008
LINCOLN, Neb. (AP) -- Nebraska Attorney General Jon Bruning has announced drug maker Cephalon (SEF-uh-lon) has paid more than $2.6 million to the state to settle allegations of off-label marketing of three pharmaceutical products.
The settlement resolves allegations that Cephalon marketed drugs for uses not approved by the Federal Drug Administration. The drugs are Actiq, a highly addictive painkiller; the anti-seizure drug Gabitril; and the sleep-disorder drug Provigil.
The money is part of a $425 million national settlement with state Medicaid programs.
The Department of Health and Human Services, which runs Nebraska's Medicaid program, will receive $334,906. Some $669,812 will go into the state's school fund, $27,772 in interest will be prorated between the Medicaid program and the school fund, and $1.6 million goes back to the federal government. The state's Medicaid program is both state and federally funded.
On the Net:
Cephalon Inc.: http://www.cephalon.com/
The settlement resolves allegations that Cephalon marketed drugs for uses not approved by the Federal Drug Administration. The drugs are Actiq, a highly addictive painkiller; the anti-seizure drug Gabitril; and the sleep-disorder drug Provigil.
The money is part of a $425 million national settlement with state Medicaid programs.
The Department of Health and Human Services, which runs Nebraska's Medicaid program, will receive $334,906. Some $669,812 will go into the state's school fund, $27,772 in interest will be prorated between the Medicaid program and the school fund, and $1.6 million goes back to the federal government. The state's Medicaid program is both state and federally funded.
On the Net:
Cephalon Inc.: http://www.cephalon.com/
Story Comments
Read More and Post Comments 0 comment(s)
Please note: The following are comments from readers. In no way do they represent the views of The Sioux City Journal or Lee Enterprises. We will not edit or alter your comments, but we do reserve the right to not post or to remove comments that violate our code of conduct. No comment may contain potentially libelous statements; obscene, explicit or racist language; personal attacks, insults or threats. Terms of Service
